Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Salzer

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|January 1, 1988
Tamoxifen in refractory ovarian cancer: the use of a loading dose scheduleR J Osborne, S T Malik, M L Slevin, et al.
Wiener Medizinische Wochenschrift (1946)|June 15, 1984
[Treatment of breast cancer at the 1st Gynecology Clinic at the University of Vienna]E Kubista, H Salzer, F Fischl, et al.
British Journal of Cancer|May 1, 1993
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancerA Rosen, P Sevelda, M Klein, et al.
Onkologie|October 1, 1987
[Effect of hormone receptors on the site of metastases in breast cancer]I Stuller, C C Zielinski, P Aiginger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Adjuvant tamoxifen in postmenopausal patients with breast cancer and negative axillary lymph nodesC Scholten, P Sevelda, C Kurz, et al.
Oncogene|September 1, 1990
Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolationF D Kury, C Schneeberger, G Sliutz, et al.
Geburtshilfe Und Frauenheilkunde|November 1, 1985
[Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients]H Salzer, E Gitsch, C Dittrich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2003
Sentinel lymph node detection with large human serum albumin colloid particles in breast cancerS Mirzaei, M Rodrigues, B Hoffmann, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1988
Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluationB Blöchl-Daum, H G Eichler, H Rainer, et al.
Onkologie|February 1, 1987
Phase-I study of intraperitoneal mitoxantrone--clinical and pharmacokinetic evaluationB Blöchl-Daum, H G Eichler, H Rainer, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|January 1, 1988
Tamoxifen in refractory ovarian cancer: the use of a loading dose scheduleR J Osborne, S T Malik, M L Slevin, et al.
Wiener Medizinische Wochenschrift (1946)|June 15, 1984
[Treatment of breast cancer at the 1st Gynecology Clinic at the University of Vienna]E Kubista, H Salzer, F Fischl, et al.
British Journal of Cancer|May 1, 1993
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancerA Rosen, P Sevelda, M Klein, et al.
Onkologie|October 1, 1987
[Effect of hormone receptors on the site of metastases in breast cancer]I Stuller, C C Zielinski, P Aiginger, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Adjuvant tamoxifen in postmenopausal patients with breast cancer and negative axillary lymph nodesC Scholten, P Sevelda, C Kurz, et al.
Oncogene|September 1, 1990
Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolationF D Kury, C Schneeberger, G Sliutz, et al.
Geburtshilfe Und Frauenheilkunde|November 1, 1985
[Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients]H Salzer, E Gitsch, C Dittrich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2003
Sentinel lymph node detection with large human serum albumin colloid particles in breast cancerS Mirzaei, M Rodrigues, B Hoffmann, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1988
Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluationB Blöchl-Daum, H G Eichler, H Rainer, et al.
Onkologie|February 1, 1987
Phase-I study of intraperitoneal mitoxantrone--clinical and pharmacokinetic evaluationB Blöchl-Daum, H G Eichler, H Rainer, et al.
Pageof 18